GNTbm-CT-01

N/A

Report date: 2022/12/04 16:40:47

Base Information

Drug NameGNTbm-CT-01
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of Actiontumor microenvironment regulator
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
China Registration ClassN/A

Develop Information

Active CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A